Articles covering wholesale sourcing of GLP-1 peptide families such as Semaglutide, Tirzepatide, Retatrutide, Survodutide and related combo kits.
Many buyers now explore a Cagrilintide + Semaglutide stack once their GLP-1 line is established. This guide explains how wholesale clients structure SKUs, plan pricing and logistics, and work with a China-based factory for dual-peptide research portfolios.
Cagrilintide is an amylin analogue that many buyers now add beside GLP-1 peptides in their metabolic portfolio. This guide explains how wholesale clients position it, what documentation to request, and how to plan factory-direct orders from China safely.
This guide compares semaglutide, tirzepatide and retatrutide from a wholesale perspective, showing how each peptide fits into a GLP-1 portfolio, how to plan pricing and MOQs, and how to brief a China-based factory for long-term supply.
Retatrutide is a high-interest triple-receptor peptide acting on GLP-1, GIP and glucagon pathways. This guide shows wholesale buyers how to plan handling, packaging, pricing and OEM projects with a China-based factory while protecting long-term supply.
Tirzepatide is shaping GLP-1/GIP peptide portfolios far beyond single-product demand. This guide walks wholesale buyers through formats, documentation, pricing structures and logistics when sourcing Tirzepatide from a China-based peptide factory for long-term projects and repeat-supply planning.
Semaglutide is one of the most requested GLP-1 peptides on the wholesale market. This guide helps factory-facing buyers plan formats, quality docs, logistics, pricing and risk checks when working with a China-based peptide supplier.
EN